DE60312502D1 - Epitopen aus dem epha2-antigen - Google Patents
Epitopen aus dem epha2-antigenInfo
- Publication number
- DE60312502D1 DE60312502D1 DE60312502T DE60312502T DE60312502D1 DE 60312502 D1 DE60312502 D1 DE 60312502D1 DE 60312502 T DE60312502 T DE 60312502T DE 60312502 T DE60312502 T DE 60312502T DE 60312502 D1 DE60312502 D1 DE 60312502D1
- Authority
- DE
- Germany
- Prior art keywords
- epitopes
- epha2 antigen
- epha2
- antigen
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 101150076616 EPHA2 gene Proteins 0.000 title 1
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 title 1
- 102000051096 EphA2 Receptor Human genes 0.000 abstract 1
- 108010055196 EphA2 Receptor Proteins 0.000 abstract 1
- 102000043129 MHC class I family Human genes 0.000 abstract 1
- 108091054437 MHC class I family Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0205048 | 2002-04-23 | ||
| FR0205048A FR2838742B1 (fr) | 2002-04-23 | 2002-04-23 | Epitopes t de l'antigene epha2 |
| PCT/FR2003/001280 WO2003091383A2 (fr) | 2002-04-23 | 2003-04-23 | Epitopes t de l'antigene epha2. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60312502D1 true DE60312502D1 (de) | 2007-04-26 |
| DE60312502T2 DE60312502T2 (de) | 2007-10-31 |
Family
ID=28686278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60312502T Expired - Lifetime DE60312502T2 (de) | 2002-04-23 | 2003-04-23 | Epitopen aus dem epha2-antigen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060034856A1 (de) |
| EP (1) | EP1497417B1 (de) |
| AT (1) | ATE356867T1 (de) |
| AU (1) | AU2003262810A1 (de) |
| CA (1) | CA2482930C (de) |
| DE (1) | DE60312502T2 (de) |
| DK (1) | DK1497417T3 (de) |
| ES (1) | ES2283791T3 (de) |
| FR (1) | FR2838742B1 (de) |
| PT (1) | PT1497417E (de) |
| WO (1) | WO2003091383A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007527225A (ja) | 2003-07-30 | 2007-09-27 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | Ｅｐｈａ２ｔ−細胞エピトープアゴニストおよびその使用 |
| WO2006034334A2 (en) * | 2004-09-21 | 2006-03-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| US7569672B2 (en) | 2005-02-04 | 2009-08-04 | Raven Biotechnologies, Inc. | Antibodies that bind to EphA2 and methods of use thereof |
| CN101171032B (zh) * | 2005-05-09 | 2012-02-29 | 瓦克松生物技术公司 | 天然肽及其优化的衍生物作为疫苗的应用 |
| HUE032301T2 (en) * | 2007-08-30 | 2017-09-28 | Daiichi Sankyo Co Ltd | Anti-EPHA2 antibody |
| EP2608799B1 (de) | 2010-08-24 | 2018-12-12 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Impfstoffe gegen hirntumore auf interleukin-13-rezeptor-alpha 2-peptid-basis |
| ES2699817T3 (es) * | 2012-03-19 | 2019-02-12 | Stemline Therapeutics Inc | Métodos para tratar y controlar el estado de un cáncer |
| EP4321218A3 (de) | 2012-05-16 | 2024-04-24 | Stemline Therapeutics, Inc. | Auf krebsstammzellen zielende krebsimpfstoffe |
| TWI505113B (zh) * | 2014-03-18 | 2015-10-21 | Vivotek Inc | 監視系統及其影像搜尋方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323016B1 (en) * | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US20040037840A1 (en) * | 2000-10-27 | 2004-02-26 | Beier Anne Mette | Novel therapeutic vaccine formulations |
| US20030216288A1 (en) * | 2002-02-15 | 2003-11-20 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules |
-
2002
- 2002-04-23 FR FR0205048A patent/FR2838742B1/fr not_active Expired - Fee Related
-
2003
- 2003-04-23 DE DE60312502T patent/DE60312502T2/de not_active Expired - Lifetime
- 2003-04-23 AT AT03740654T patent/ATE356867T1/de active
- 2003-04-23 DK DK03740654T patent/DK1497417T3/da active
- 2003-04-23 EP EP03740654A patent/EP1497417B1/de not_active Expired - Lifetime
- 2003-04-23 CA CA2482930A patent/CA2482930C/fr not_active Expired - Fee Related
- 2003-04-23 US US10/511,273 patent/US20060034856A1/en not_active Abandoned
- 2003-04-23 ES ES03740654T patent/ES2283791T3/es not_active Expired - Lifetime
- 2003-04-23 WO PCT/FR2003/001280 patent/WO2003091383A2/fr active IP Right Grant
- 2003-04-23 PT PT03740654T patent/PT1497417E/pt unknown
- 2003-04-23 AU AU2003262810A patent/AU2003262810A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1497417B1 (de) | 2007-03-14 |
| DK1497417T3 (da) | 2007-06-25 |
| ATE356867T1 (de) | 2007-04-15 |
| US20060034856A1 (en) | 2006-02-16 |
| AU2003262810A1 (en) | 2003-11-10 |
| FR2838742A1 (fr) | 2003-10-24 |
| EP1497417A2 (de) | 2005-01-19 |
| FR2838742B1 (fr) | 2004-07-09 |
| AU2003262810A8 (en) | 2003-11-10 |
| DE60312502T2 (de) | 2007-10-31 |
| CA2482930A1 (fr) | 2003-11-06 |
| CA2482930C (fr) | 2013-08-13 |
| WO2003091383A2 (fr) | 2003-11-06 |
| ES2283791T3 (es) | 2007-11-01 |
| WO2003091383A3 (fr) | 2004-04-01 |
| PT1497417E (pt) | 2007-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR122018016045B8 (pt) | proteína variante otimizada | |
| CY1115147T1 (el) | Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17 | |
| BRPI0517973B8 (pt) | métodos para purificar o fsh recombinante | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
| CY1112507T1 (el) | Μορια αντισωματος που εχουν ειδικοτητα για την ανθρωπινη ιl-1β | |
| AR060998A1 (es) | Anticuerpo monoclonal anti cd40 humana antagonista | |
| ATE542829T1 (de) | Impfstoff | |
| NO20062579L (no) | Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener | |
| MX338940B (es) | Identificacion de epitopos ige novedosos. | |
| CY1107681T1 (el) | Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων | |
| ATE356867T1 (de) | Epitopen aus dem epha2-antigen | |
| DK1362109T3 (da) | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale | |
| NO20081043L (no) | Vaksine for fisk | |
| WO2005058937A3 (en) | A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 | |
| DE60228971D1 (de) | Peptide aus dem g-protein des respiratorischen synzytialvirus und deren verwendung in einem impfstoff | |
| ATE412427T1 (de) | Cd40-ligand als adjuvant für respiratorisches syncytialvirus-impfstoff | |
| NO20072705L (no) | Alfa-tymosinpeptider som cancervaksineadjuvanser | |
| DK1397380T3 (da) | Multipelt antigent peptid, der udviser flere kopier af en epitop af et plaquedannende polypeptid, og fremgangmåder til anvendelse deraf | |
| WO2004030616A3 (en) | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES | |
| ES2502366T3 (es) | Inducción de inmunidad tumoral por variantes de proteína de unión a folato | |
| DE60219215D1 (de) | Prionen-bindende peptidsequenzen | |
| EA200400897A1 (ru) | Иммуногенные композиции из вариабельных пептидных эпитопов и способ их получения | |
| DK1625152T3 (da) | Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktoren | |
| DE50207723D1 (de) | Kosmetische Zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |